Science Explorer Interactive view Map
Company · Valencia · United States

MannKind Corporation (United States)

mannkindcorp.comROR OpenAlex
Research works
56
▼ 59% vs 2013–17
Citations
1.8k
32.0 per fractional work
Top-10% rate
37.4%
record average 16.5%
Open access
41%
world 28%

Not ranked overall: MannKind Corporation (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.70× its world share, 0 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 22.98× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.38× its world share, 0 worksChemistryEngineering: 0.17× its world share, 0 worksEngineeringHealth Professions: 4.61× its world share, 0 worksHealth ProfessionsMedicine: 3.58× its world share, 3 worksMedicineSocial Sciences: 0.07× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 23.0×. Every wedge is a field page.

Which keywords describe research at MannKind Corporation (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Inhaler Devices, Pulmonary Drug Delivery, Immunity, Antigen Presentation, Glycemic Control, Type 1 Diabetes and Innate Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Nanoparticles8▲ 11×2 topics
  2. Inhaler Devices7▲ 405×1 topic
  3. Pulmonary Drug Delivery7▲ 405×1 topic
  4. Immunity5▲ 28×4 topics
  5. Antigen Presentation5▲ 86×2 topics
  6. Epidemiology5▲ 2.2×12 topics
  7. Inflammation4▲ 3.4×9 topics
  8. Cancer Immunotherapy4▲ 55×2 topics
  9. Glycemic Control4▲ 57×4 topics
  10. Innate Immunity4▲ 22×3 topics
  11. Type 1 Diabetes4▲ 84×2 topics
  12. Insulin Therapy4▲ 70×3 topics
  13. Dendritic Cells4▲ 63×1 topic
  14. Tumor Antigen4▲ 90×1 topic
  15. Cardiovascular Disease4▲ 6.0×3 topics
  16. Diabetes4▲ 12×3 topics
  17. Complications3▲ 12×2 topics
  18. Continuous Glucose Monitoring3▲ 128×1 topic
  19. Hypoglycemia3▲ 128×1 topic
  20. Autoimmunity3▲ 25×2 topics
  21. Genetics3▲ 6.0×2 topics
  22. NK Cell Recognition3▲ 46×1 topic
  23. Natural Killer Cells3▲ 46×1 topic
  24. Oxidative Stress3▲ 2.5×4 topics
  25. Monoclonal Antibodies2▲ 30×3 topics
  26. TGF-ß2▲ 22×2 topics
  27. Apoptosis2▲ 9.2×2 topics
  28. Asthma2▲ 27×2 topics
  29. Tumor Microenvironment2▲ 10.0×2 topics
  30. CD4+CD25+2▲ 43×1 topic
  31. Clinical Trials2▲ 5.1×2 topics
  32. Foxp32▲ 43×1 topic
  33. Therapeutic Antibodies2▲ 24×2 topics
  34. Off-Label Drug Use2▲ 79×1 topic
  35. Pediatric Pharmacokinetics2▲ 79×1 topic
  36. Immune Checkpoint Blockade2▲ 50×1 topic
  37. PD-1 and PD-L12▲ 50×1 topic
  38. Allergic Diseases2▲ 33×1 topic
  39. Eosinophils2▲ 33×1 topic
  40. Protein Folding2▲ 50×2 topics

Which research topics does MannKind Corporation (United States) publish most on?

By volume in 2022–2025: Diabetes Management and Research, Health and Lifestyle Studies, Inhalation and Respiratory Drug Delivery and Quinazolinone synthesis and applications.

Diabetes Management and …1Diabetes Management and Research: 1 fractional worksHealth and Lifestyle Stu…0Health and Lifestyle Studies: 0 fractional worksInhalation and Respirato…0Inhalation and Respiratory Drug Delivery: 0 fractional worksQuinazolinone synthesis and applications: 0 fractional worksTuberculosis Research and Epidemiology: 0 fractional worksDiabetes Treatment and Management: 0 fractional worksDiet and metabolism studies: 0 fractional worksAdvancements in Transdermal Drug Delivery: 0 fractional worksPharmaceutical studies and practices: 0 fractional worksReceptor Mechanisms and Signaling: 0 fractional works
Endocrinology, Diabetes and MetabolismGeneral Health ProfessionsPulmonary and Respiratory MedicineOrganic Chemistry5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  2. 2 Health and Lifestyle Studies General Health Professions 0 works
  3. 3 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  4. 4 Quinazolinone synthesis and applications Organic Chemistry 0 works
  5. 5 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
  6. 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  7. 7 Diet and metabolism studies Physiology 0 works
  8. 8 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  10. 10 Receptor Mechanisms and Signaling Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.3%not open58.7%

World: 28% of research is openly available.

with international co-authors28.8%domestic only71.2%

World: 19% is written across borders.

How has MannKind Corporation (United States)'s research output changed?

Output in 2018–2022 was 59% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Valencia

All research institutions in Valencia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.